Vanda Pharmaceuticals Inc (VNDA)
4.675
-0.10
(-2.09%)
USD |
NASDAQ |
Dec 23, 16:00
4.675
0.00 (0.00%)
After-Hours: 20:00
Vanda Pharmaceuticals Shareholders Equity (Quarterly): 541.22M for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Zevra Therapeutics Inc | 69.77M |
| Black Diamond Therapeutics Inc | 97.43M |
| NovaBay Pharmaceuticals Inc | 1.072M |
| Palatin Technologies Inc | -7.686M |
| iBio Inc | 17.75M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 645.12M |
| Total Liabilities (Quarterly) | 103.89M |
| Current Ratio | 4.853 |